A detailed history of Tfb Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tfb Advisors LLC holds 4,787 shares of BMY stock, worth $286,980. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,787
Previous 4,166 14.91%
Holding current value
$286,980
Previous $215,000 25.58%
% of portfolio
0.08%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$51.92 - $59.94 $32,242 - $37,222
621 Added 14.91%
4,787 $270,000
Q3 2024

Oct 31, 2024

BUY
$39.66 - $51.75 $165,223 - $215,590
4,166 New
4,166 $215,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $127B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tfb Advisors LLC Portfolio

Follow Tfb Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfb Advisors LLC with notifications on news.